NO975661L - Anvendelse av bis-1,2,4-triazoler for fremstilling av et medikament for behandling av cancer - Google Patents

Anvendelse av bis-1,2,4-triazoler for fremstilling av et medikament for behandling av cancer

Info

Publication number
NO975661L
NO975661L NO975661A NO975661A NO975661L NO 975661 L NO975661 L NO 975661L NO 975661 A NO975661 A NO 975661A NO 975661 A NO975661 A NO 975661A NO 975661 L NO975661 L NO 975661L
Authority
NO
Norway
Prior art keywords
bis
preparation
triazoles
cancer
drug
Prior art date
Application number
NO975661A
Other languages
English (en)
Norwegian (no)
Other versions
NO975661D0 (no
Inventor
James Berger Camden
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO975661D0 publication Critical patent/NO975661D0/no
Publication of NO975661L publication Critical patent/NO975661L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/402—1-aryl substituted, e.g. piretanide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO975661A 1995-06-07 1997-12-05 Anvendelse av bis-1,2,4-triazoler for fremstilling av et medikament for behandling av cancer NO975661L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/473,818 US5665751A (en) 1995-06-07 1995-06-07 Pharmaceutical composition for inhibiting the growth of cancers
PCT/US1996/007446 WO1996040120A1 (en) 1995-06-07 1996-05-22 Use of bis-1,2,4-triazoles for the manufacture of a medicament for the treatment of cancers

Publications (2)

Publication Number Publication Date
NO975661D0 NO975661D0 (no) 1997-12-05
NO975661L true NO975661L (no) 1998-02-09

Family

ID=23881116

Family Applications (1)

Application Number Title Priority Date Filing Date
NO975661A NO975661L (no) 1995-06-07 1997-12-05 Anvendelse av bis-1,2,4-triazoler for fremstilling av et medikament for behandling av cancer

Country Status (20)

Country Link
US (3) US5665751A (hu)
EP (1) EP0831815A1 (hu)
JP (1) JPH11506733A (hu)
KR (1) KR19990022618A (hu)
CN (1) CN1259867A (hu)
AR (1) AR003430A1 (hu)
AU (1) AU717201B2 (hu)
BR (1) BR9609093A (hu)
CA (1) CA2223803A1 (hu)
CZ (1) CZ391897A3 (hu)
HU (1) HUP9802629A3 (hu)
IL (1) IL118426A (hu)
NO (1) NO975661L (hu)
NZ (1) NZ308393A (hu)
PL (1) PL324078A1 (hu)
SK (1) SK168797A3 (hu)
TR (2) TR200102287T2 (hu)
TW (1) TW466113B (hu)
WO (1) WO1996040120A1 (hu)
ZA (1) ZA964377B (hu)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9507164A (pt) * 1994-03-21 1997-09-09 John Brown Thomsen Composiçao farmacêutica em forma de gel para o tratamento de distúrbios da pele processo de tratamento de pele e uso de uma combinaçao de um agente gelificante de polimero e um alcanol inferior de etil hidroxietil celulose e de um alcanol inferior
US6262093B1 (en) 1995-04-12 2001-07-17 The Proctor & Gamble Company Methods of treating cancer with benzimidazoles
US6479526B1 (en) 1995-04-12 2002-11-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
US6177460B1 (en) 1995-04-12 2001-01-23 The Procter & Gamble Company Method of treatment for cancer or viral infections
US5770616A (en) * 1995-06-07 1998-06-23 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers
US6265427B1 (en) 1995-06-07 2001-07-24 The Proctor & Gamble Company Pharmaceutical composition for the method of treating leukemia
US6686391B2 (en) 1995-08-04 2004-02-03 University Of Arizona Foundation N-chlorophenylcarbamate and N-chlorophenylthiocarbamate compositions
BR9609966A (pt) * 1995-08-04 1999-02-02 Procter & Gamble Uso de fluconazol para a inibição do desenvolvimento de cânceres
US5900429A (en) 1997-01-28 1999-05-04 The Procter & Gamble Company Method for inhibiting the growth of cancers
US6506783B1 (en) * 1997-05-16 2003-01-14 The Procter & Gamble Company Cancer treatments and pharmaceutical compositions therefor
US6245789B1 (en) 1998-05-19 2001-06-12 The Procter & Gamble Company HIV and viral treatment
US6136835A (en) * 1999-05-17 2000-10-24 The Procter & Gamble Company Methods of treatment for viral infections
US6423734B1 (en) * 1999-08-13 2002-07-23 The Procter & Gamble Company Method of preventing cancer
US6462062B1 (en) * 2000-09-26 2002-10-08 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6608096B1 (en) 2000-09-26 2003-08-19 University Of Arizona Foundation Compounds and methods for use thereof in the treatment of cancer or viral infections
US6380232B1 (en) 2000-09-26 2002-04-30 The Procter & Gamble Company Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
US6407105B1 (en) 2000-09-26 2002-06-18 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6515074B2 (en) * 2001-01-22 2003-02-04 Delphi Technologies, Inc. Thermoplastic polymer alloy compositions and process for manufacture thereof
CN100334084C (zh) * 2005-04-26 2007-08-29 武汉大学 联三唑化合物及其制备方法和用途
CN100451007C (zh) * 2006-10-12 2009-01-14 杭州宇龙化工有限公司 含芳醚双三氮唑类化合物及其用途
US8278415B2 (en) 2006-12-21 2012-10-02 Centocor, Inc. Dimeric high affinity EGFR constructs and uses thereof
US8834920B2 (en) 2006-12-21 2014-09-16 Alza Corporation Liposome composition for targeting egfr receptor
WO2008079973A2 (en) 2006-12-21 2008-07-03 Centocor, Inc. Egfr binding peptides and uses thereof
KR100980328B1 (ko) * 2007-12-14 2010-09-06 한국생명공학연구원 단백질 포스파타제의 활성을 억제하는트리아졸릴-티오-에타논 유도체 또는 이의 약학적으로 허용가능한 염을 유효성분으로 함유하는 암 예방 및 치료용조성물
CN102321036A (zh) * 2011-07-13 2012-01-18 王健祥 一种氟康唑可溶性盐的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4079062A (en) * 1974-11-18 1978-03-14 Janssen Pharmaceutica N.V. Triazole derivatives
US4160838A (en) * 1977-06-02 1979-07-10 Janssen Pharmaceutica N.V. Antimicrobial and plant-growth-regulating triazole derivatives
GB2078719B (en) * 1980-06-02 1984-04-26 Ici Ltd Heterocyclic compounds
DE3262386D1 (en) * 1981-06-06 1985-03-28 Pfizer Ltd Antifungal agents, processes for their preparation, and pharmaceutical compositions containing them
DE3837463A1 (de) * 1988-11-04 1990-05-10 Bayer Ag Substituierte bisazole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
BE1004029A6 (nl) * 1990-11-22 1992-09-08 Mol Omer De Farmaceutische samenstelling en farmaceutische set voor het behandelen van kanker.
US5360612A (en) * 1992-10-13 1994-11-01 Pfizer Inc. Pharmaceutical compositions containing triazole derivatives for rectal administration

Also Published As

Publication number Publication date
CA2223803A1 (en) 1996-12-19
ZA964377B (en) 1997-02-17
US5840742A (en) 1998-11-24
CN1259867A (zh) 2000-07-12
CZ391897A3 (cs) 1998-05-13
USRE37003E (en) 2000-12-26
PL324078A1 (en) 1998-05-11
JPH11506733A (ja) 1999-06-15
EP0831815A1 (en) 1998-04-01
IL118426A (en) 2001-03-19
AU5802196A (en) 1996-12-30
KR19990022618A (ko) 1999-03-25
NZ308393A (en) 2001-04-27
AU717201B2 (en) 2000-03-23
TR200102287T2 (tr) 2002-06-21
TR199701535T1 (xx) 1998-03-21
US5665751A (en) 1997-09-09
NO975661D0 (no) 1997-12-05
HUP9802629A3 (en) 2000-01-28
IL118426A0 (en) 1996-09-12
HUP9802629A2 (hu) 1999-04-28
WO1996040120A1 (en) 1996-12-19
TW466113B (en) 2001-12-01
AR003430A1 (es) 1998-08-05
SK168797A3 (en) 1998-12-02
BR9609093A (pt) 1999-06-29

Similar Documents

Publication Publication Date Title
NO975661L (no) Anvendelse av bis-1,2,4-triazoler for fremstilling av et medikament for behandling av cancer
NO974694L (no) Farmasöytisk preparat som inneholder N-fosfonoglycin-derivater for å inhibere vekst av cancer og virus
DK0527879T3 (da) Synergistiske terapeutiske præparater og fremgangsmåder.
NO910340L (no) Topiske preparater for behandling av menneskenegler.
NO975662L (no) Anvendelse av 1,2,4-triazolderivater for fremstilling av et medikament for behandling av cancer
NO986089D0 (no) Metoder og preparater for behandling av tumorer, tumorrelaterte sykdommer o
NO2009028I1 (no) Kinazolin-derivater, anvendelse og fremstilling derav, samt farmasøytisk preparat
TR199500832A2 (tr) Benzimidazol türevleri ve bunlarin medikal terapide kullanimi ve bunlari iceren farmasötik formülasyonlar.
ATE197670T1 (de) Parenterales busulfan zur behandlung von malignen krankheiten
SE9401728D0 (sv) New compounds II
NO974693L (no) Farmasöytisk preparat inneholdende N-klorfenylkarbamater, N-klorfenyltiokarbamater og N-fosfonoglycin-derivater for å inhibere vekst av cancer og virus i pattedyr
SE8000435L (sv) N-bensylimidazoler med selektivt inhiberande verkan pa tromboxansyntetasenzymet jemte farmaceutiska beredningar innehallande sadana n-bensylimidazoler och sett for deras framstellning
NO954878L (no) Pyrrolderivater
NO974696D0 (no) Farmasöytisk preparat inneholdende N-klor-fenylkarbamater og N-klorfenyltiokarbamater for inhibering av vekst av virus og cancer
NO891293D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive imidazol - og triazol-derivater.
EE9900162A (et) Rinnavähi vältimise meetod, farmatseutiline preparaat ja toode ning toimeaine kasutamine
TR199900661T2 (xx) Cilt enfeksiyonlar�n�n tedavisi amac�yla 1-hidroksi-2-piridonlar�n kullan�m�
DK0573492T3 (da) Præparater indeholdende fluticasonpropionat og oxiconazol eller salte deraf til topisk administration
NO943288L (no) Anvendelse av pentoksyfyllin ved fremstilling av farmasöytiske preparater til behandling av granulomatöse og fibroserende lungesykdommer
NO931342D0 (no) Benzimidazoler, medisinske preparater inneholdende disse,og fremgangsmaate for deres fremstilling
AU1858992A (en) 2-(1-piperidyl)ethanol derivatives, their preparation and their therapeutic application
FR2779429B1 (fr) Derives d'oxindole, leurs preparations et leurs applications en therapeutique
NO891046D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,2,4-triazol-derivater.
AU8715491A (en) Melatonin derivative having therapeutic activity in dermatology
DK0468258T3 (da) Substituerede pyridooxaziner

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application